BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6811336)

  • 1. Effect of body weight reduction on plasma androgens in obese, infertile women.
    Bates GW; Whitworth NS
    Fertil Steril; 1982 Oct; 38(4):406-9. PubMed ID: 6811336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone suppresses sex-hormone binding globulin.
    Blake RE; Rajguru S; Nolan GH; Ahluwalia BS
    Fertil Steril; 1988 Jan; 49(1):66-70. PubMed ID: 3121398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage migration inhibitory factor in obese and non obese women with polycystic ovary syndrome.
    Mejia-Montilla J; Álvarez-Mon M; Reyna-Villasmil E; Torres-Cepeda D; Santos-Bolívar J; Reyna-Villasmil N; Suarez-Torres I; Bravo-Henríquez A
    Endocrinol Nutr; 2015 Jan; 62(1):31-7. PubMed ID: 25458401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
    Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
    J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma renin and aldosterone levels in obese and non-obese women with polycystic ovary syndrome].
    Mejia-Montilla J; Reyna-Villasmil E; Torres-Cepeda D; Santos-Bolívar J; Reyna-Villasmil N; Bravo-Henríquez A
    Endocrinol Nutr; 2012 Jan; 59(1):21-7. PubMed ID: 22115703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
    Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
    J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Insulin resistance and serum concentrations of ovarian and adrenal androgen in obese women without additional disease and with policystic ovary syndrome].
    Olszanecka-Glinianowicz M; Banaś M; Zahorska-Markiewicz B; Kuglin D; Mokrzycka J; Mentel A
    Endokrynol Pol; 2005; 56(6):921-6. PubMed ID: 16821212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases.
    Kiddy DS; Sharp PS; White DM; Scanlon MF; Mason HD; Bray CS; Polson DW; Reed MJ; Franks S
    Clin Endocrinol (Oxf); 1990 Feb; 32(2):213-20. PubMed ID: 2112067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of the synchronous secretion of leptin, LH, and ovarian androgens in nonobese adolescents with the polycystic ovarian syndrome.
    Veldhuis JD; Pincus SM; Garcia-Rudaz MC; Ropelato MG; Escobar ME; Barontini M
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3772-8. PubMed ID: 11502810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.
    Insler V; Barash A; Shoham Z; Koistinen R; Seppala M; Hen M; Lunenfeld B; Zadik Z
    Isr J Med Sci; 1994 Jan; 30(1):42-7. PubMed ID: 7511134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasonography of the ovaries and its correlation with clinical and endocrine parameters in infertile women with PCOS.
    Sikka P; Gainder S; Dhaliwal LK; Bagga R; Sialy R; Sahdev S
    Int J Fertil Womens Med; 2007; 52(1):41-7. PubMed ID: 17987887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of continuous androgen secretion on the hypothalamic-pituitary axis in woman: evidence from a luteinized thecoma of the ovary.
    Dunaif A; Scully RE; Andersen RN; Chapin DS; Crowley WF
    J Clin Endocrinol Metab; 1984 Sep; 59(3):389-93. PubMed ID: 6086692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease.
    Toscano V; Balducci R; Bianchi P; Mangiantini A; Sciarra F
    J Clin Endocrinol Metab; 1990 Aug; 71(2):288-92. PubMed ID: 2166066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and its role in polycystic ovary syndrome.
    Plymate SR; Fariss BL; Bassett ML; Matej L
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1246-8. PubMed ID: 6785298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating anti-Müllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome.
    Olszanecka-Glinianowicz M; Madej P; Owczarek A; Chudek J; Skałba P
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):98-104. PubMed ID: 25440474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in plasma levels of androgens and SHBG in patients with polycystic ovary syndrome (PCOs) treated with oral contraceptives containing desogestrel].
    Negri P; D'Errico G; Minisci N; Tomasi A
    Minerva Ginecol; 1988 Dec; 40(12):699-707. PubMed ID: 2977429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.